Skip to main content

Advertisement

SpringerLink
Log in

Vasculitis in the connective tissue diseases

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Vasculitides in the setting of connective tissue diseases are generally thought to be infrequent and relatively little is written about them. They are, however, important both because they may pose diagnostic and therapeutic challenges and affect prognosis. In each of the connective tissue diseases, vasculitis can present in various clinical and pathologic forms adding to their diagnostic and therapeutic difficulties. This article reviews recent information on the frequency, characteristics, and possible pathogenic mechanisms of the vasculitides occurring in patients with the main connective tissue diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Gladman DD, Urowitz MB: Systemic lupus erythematosus: clinical features. In Rheumatology. Edited by Klippel JH, Dieppe PA. London: Mosby; 1998 (Section 7.1):1–18.

    Google Scholar 

  2. Drenkard C, Villa AR, Reyes E, et al.:Vasculitis in systemic lupus erythematosus. Lupus 1997, 6:235–242. This is the largest and most detailed study of vasculitis in systemic lupus erythematosus. An association of vasculitis with antiphospholipid antibodies and the antiphospholipid syndrome is well demonstrated.

    PubMed  CAS  Google Scholar 

  3. Carreño L, López-Longo FJ, Monteagudo I, et al.:Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus 1999, 8:287–292.

    Article  PubMed  Google Scholar 

  4. Alarcón-Segovia D, Alarcón-Riquelme ME: Etiopathogenesis of systemic lupus erythematosus: a tale of three troikas. In Systemic Lupus Erythematosus. Edited by Lahita RG. San Diego: Academic Press; 1999:55–65.

    Google Scholar 

  5. Shoenfeld Y, Alarcón-Segovia D, Buskila D, et al.:Frontiers of SLE: review of the 5th International Congress of systemic lupus erythematosus, Cancún, México, April 20–25, 1998. Semin Arthritis Rheum 1999, 29:112–130.

    Article  PubMed  CAS  Google Scholar 

  6. Carvalho D, Savage COS, Isenberg D, Pearson JD: IgG antiendothelial cell autoantibodies from patients with systemic lupus erythematosus stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 1999, 42:631–640.

    Article  PubMed  CAS  Google Scholar 

  7. Reyes E, Alarcón-Segovia D: Leg ulcers in the primary antiphospholipid syndrome: report of a case with a peculiar proliferative small vessel vasculopathy. Clin Exp Rheumatol 1991, 9:63–66.

    PubMed  CAS  Google Scholar 

  8. Del Papa N, Sheng YH, Raschi E, et al.:Human b2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti b2-glycoprotein I antibodies. J Immunol 1998, 160:5572–5578. A good demonstration of the interplay of several actors in the pathogenesis of the antiphospholipid syndrome that may help understand its association with vasculitis.

    Google Scholar 

  9. Villarreal GM, Drenkard C, Villa AR, et al.:Prevalence of 13 autoantibodies and of the 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity. Lupus 1997, 6:425–435.

    PubMed  CAS  Google Scholar 

  10. Chan OWT, Madaio MP, Shlomchik MJ: B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J Immunol 1999, 163:3592–3596. This study demonstrates the requirement for B cells in the development of vasculitis in an animal model of systemic lupus erythematosus with resultant diminution of CD4 and CD8 positive T cells.

    PubMed  CAS  Google Scholar 

  11. Singer GG, Carrera AC, Marshak-Rothstein A, et al.:Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr Opin Immunol 1994, 6:913–920.

    Article  PubMed  CAS  Google Scholar 

  12. Chan OT, Hannum LG, Haberman AM, et al.:A novel mouse with B cells but lacking serum antibody reveals an antibodyindependent role for B cells in murine lupus. J Exp Med 1999, 189:1639–1647. B cells that are incapable of secreting autoantibodies still participate in the development of vasculitis in a murine lupus model.

    Article  PubMed  CAS  Google Scholar 

  13. Luzina IG, Knitzer RH, Atamas SP, et al.: Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells. Arthritis Rheum 1999,

  14. Llorente L, Zou W, Levy Y, et al.:Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995, 181:839–844.

    Article  PubMed  CAS  Google Scholar 

  15. Witte T, Hartung K, Sachse C, et al.:Thrombomodulin in systemic lupus erythematosus: association with clinical and laboratory parameters. Rheumatol Int 1999, 19:15–18.

    Article  PubMed  CAS  Google Scholar 

  16. Bacon PA, Carruthers DM: Vasculitis associated with connective tissue disorders. Rheum Dis Clin North Am 1995, 21:1077–1096.

    PubMed  CAS  Google Scholar 

  17. Sundy JS, Haynes BF: Rheumatoid arthritis. In The Autoimmune Diseases. Edited by Rose NR, Mackay IR. San Diego: Academic Press; 1998:343–380.

    Google Scholar 

  18. Bacon PA, Kitas GD: The significance of vascular inflammation in rheumatoid arthritis. Ann Rheum Dis 1994, 53:621–623.

    Google Scholar 

  19. Schwarz MI, Zamora MR, Hodges TN, et al.:Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Chest 1998, 113:1609–1615.

    PubMed  CAS  Google Scholar 

  20. Turesson C, Jacobson L, Bergström U: Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology 1999, 38:668–674.

    Article  PubMed  CAS  Google Scholar 

  21. Kuryliszyn-Moskal A: Cytokines and soluble CD4 and CD8 molecules in rheumatoid arthritis: relationship to systematic vasculitis and microvascular capillaroscopic abnormalities. Clin Rheumatol 1998, 17:489–495.

    Article  PubMed  CAS  Google Scholar 

  22. Prigione I, Buoncompagni A, Cutolo M, et al.:Normal levels of soluble CD4 in sera from patients with juvenile chronic arthritis. Clin Exp Rheumatol 1993, 11:341–344.

    PubMed  CAS  Google Scholar 

  23. Blann AD, Herrick A, Jayson MIV: Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. Br J Rheumatol 1995, 34:814–819.

    Article  PubMed  CAS  Google Scholar 

  24. Salih AM, Nixon NA, Dawes PT, Mattey DL: Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy. J Rheumatol 1999, 26:551–555.

    PubMed  CAS  Google Scholar 

  25. Alarcón-Segovia D, Cardiel MH, Reyes E: Antiphospholipid arterial vasculopathy. J Rheumatol 1989, 16:762–767.

    PubMed  Google Scholar 

  26. Gibson GE, Su WPD, Pittelkow MR: Antiphospholipid syndrome and the skin. J Am Acad Dermatol 1997, 36:970–982.

    Article  PubMed  CAS  Google Scholar 

  27. Norden DK, Ostrov BE, Shafritz AB, von Feldt JM: Vasculitis associated with antiphospholipid syndrome. Semin Arthritis Rheum 1995, 24:273–281.

    Article  PubMed  CAS  Google Scholar 

  28. Goldberger E, Elder RC, Schwartz RA, Phillips PE: Vasculitis in the antiphospholipid syndrome. Arthritis Rheum 1992, 35:569–572.

    Article  PubMed  CAS  Google Scholar 

  29. Cervera R, Khamashta MA, Font J, et al.:Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity 1991, 11:1–6.

    PubMed  CAS  Google Scholar 

  30. Tsokos M, Lazarou SA, Moutsopoulos HM: Vasculitis in primary Sjögren’s syndrome. Histologic classification and clinical presentation. Am J Clin Pathol 1987, 88:26–31.

    PubMed  CAS  Google Scholar 

  31. Tzioufas AG, Moutsopoulos HM: Sjögren’s syndrome. In Rheumatology. Edited by Klippel JH, Dieppe PA. London: Mosby; 1998:1–12.

    Google Scholar 

  32. Praprotnik S, Bozic B, Kveder T, Rozman B: Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjögren’s syndrome: a prospective study. Clin Exp Rheumatol 1999, 17:63–68.

    PubMed  CAS  Google Scholar 

  33. Alexander EL, Provost TT: Cutaneous manifestations of primary Sjögren’s syndrome: a reflection of vasculitis and association with anti-Ro (SS-A) antibodies. J Invest Dermatol 1983, 80:386–391.

    Article  PubMed  CAS  Google Scholar 

  34. Niemela RK, Hakala M: Primary Sjögren’s syndrome with severe central nervous system disease. Semin Arthritis Rheum 1999, 29:4–13.

    Article  PubMed  CAS  Google Scholar 

  35. Huerta-Yañez G, Sánchez-Guerrero J, Reyes E, Alarcón-Segovia D: Vasculitis en enfermedad mixta del tejido conjuntivo (EMTC) [abstract]. Rev Mex Reumatol 1989, 4:3.

    Google Scholar 

  36. Kraus A, Cervantes G, Barojas E, Alarcón-Segovia D: Retinal vasculitis in mixed connective tissue disease. A fluoroangiographic study. J Rheumatol 1985, 12:1122–1124.

    PubMed  CAS  Google Scholar 

  37. Ishikawa O, Tamura T, Ohnishi K, et al.:Systemic sclerosis terminating as systemic necrotizing angiitis. Br J Dermatol 1993, 129:736–738.

    Article  PubMed  CAS  Google Scholar 

  38. Herrick AL, Oogarah PK, Freemont AJ, et al.:Vasculitis in patients with systemic sclerosis and severe digital ischaemia requiring amputation. Ann Rheum Dis 1994, 53:323–326.

    PubMed  CAS  Google Scholar 

  39. Oddis CV, Eisenbeis CH Jr, Reidbord HE, et al.:Vasculitis in systemic sclerosis: association with Sjögren’s syndrome and the CREST syndrome variant. J Rheumatol 1987, 14:942–948.

    PubMed  CAS  Google Scholar 

  40. Dyck PJB, Hunder GG, Dyck PJ: A case-control and nerve biopsy study of CREST multiple mononeuropathy. Neurology 1997, 49:1641–1645. Of a large group of patients with CREST syndrome, the authors study in detail those who had neuropathy, mostly related to vasculitis.

    PubMed  CAS  Google Scholar 

  41. Banker BQ, Victor M: Dermatomyositis (systemic angiopathy) in childhood. Medicine 1966, 45:261–289.

    Article  PubMed  CAS  Google Scholar 

  42. Koh ET, Seow A, Ong B, et al.:Adult onset polymyositis/ dermatomyositis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis 1993, 52:857–861.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology and Rheumatology, Instituto Nacional de la Nutrición Salvador, Vasco de Quiroga 15, 14000, Mexico D.F., Mexico

    Luis Felipe Flores-Suárez MD & Donato Alarcón-Segovia MD, MS, MACP

Authors
  1. Luis Felipe Flores-Suárez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Donato Alarcón-Segovia MD, MS, MACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flores-Suárez, L.F., Alarcón-Segovia, D. Vasculitis in the connective tissue diseases. Curr Rheumatol Rep 2, 396–401 (2000). https://doi.org/10.1007/s11926-000-0039-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-000-0039-1

Keywords

Search

Navigation